Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
The publication evaluates the safety and immunogenicity of COVID-19 vaccines in immunocompromised patients, particularly those undergoing cancer treatment.
It highlights that while vaccine responses in these populations may be diminished compared to the general population, vaccination remains crucial for protection against severe disease.
The study emphasizes the importance of tailored vaccination strategies and ongoing monitoring to optimize outcomes in cancer patients.